资讯
Grace Therapeutics, Inc. has announced positive results from its Phase 3 STRIVE-ON trial for GTx-104, an injectable formulation of nimodipine aimed at treating aneurysmal Subarachnoid Hemorrhage ...
Nimodipine 30mg; soft-gel caps. Take on empty stomach. 60mg every 4 hours for 21 consecutive days. Start within 96 hours of subarachnoid hemorrhage. If oral therapy is not feasible, may extract ...
Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia. Nimodipine is a calcium-channel blocker with specific cerebral vasodilator activity. Our objective was ...
HONOLULU — In a phase 3 randomized trial, a single injection of an investigational sustained-release nimodipine formulation significantly reduced the risk for vasospasm after aneurysmal ...
(Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address ...
Nimodipine, available only as an oral capsule, is used in critical-care settings to treat neurologic complications from subarachnoid hemorrhage. The FDA states that it continues to receive reports ...
Nimodipine is a calcium channel blocker, prescribed for brain hemorrhage (bleeding in the brain) and also rarely used for high blood pressure. We recommend consulting your doctor to verify the ...
Even slight injuries can kill the sensitive cells. The drug nimodipine could help prevent this. It is currently being used to treat cerebral hemorrhages. The drug relaxes blood vessels which can ...
Details concerning the Nimodipine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果